Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 8673

1.

A Phase IIa Randomized Control Trial of VEL015 (Sodium Selenate) in Mild-Moderate Alzheimer's Disease.

Malpas CB, Vivash L, Genc S, Saling MM, Desmond P, Steward C, Hicks RJ, Callahan J, Brodtmann A, Collins S, Macfarlane S, Corcoran NM, Hovens CM, Velakoulis D, O'Brien TJ.

J Alzheimers Dis. 2016 Jul 22. [Epub ahead of print]

PMID:
27447428
2.

Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine.

Chiasserini D, Biscetti L, Farotti L, Eusebi P, Salvadori N, Lisetti V, Baschieri F, Chipi E, Frattini G, Stoops E, Vanderstichele H, Calabresi P, Parnetti L.

J Alzheimers Dis. 2016 Jul 22. [Epub ahead of print]

PMID:
27447425
3.

Neuronal Pentraxin 2 Predicts Medial Temporal Atrophy and Memory Decline Across the Alzheimer's Disease Spectrum.

Swanson A; Alzheimer’s Disease Neuroimaging Initiative, Willette AA.

Brain Behav Immun. 2016 Jul 18. pii: S0889-1591(16)30342-7. doi: 10.1016/j.bbi.2016.07.148. [Epub ahead of print]

PMID:
27444967
4.

Timosaponin B-II ameliorates scopolamine-induced cognition deficits by attenuating acetylcholinesterase activity and brain oxidative damage in mice.

Zhao X, Liu C, Qi Y, Fang L, Luo J, Bi K, Jia Y.

Metab Brain Dis. 2016 Jul 22. [Epub ahead of print]

PMID:
27444169
5.

Diffusion tensor studies and voxel-based morphometry of the temporal lobe to determine the cognitive prognosis in cases of Alzheimer's disease and mild cognitive impairment: Do white matter changes precede gray matter changes?

Taoka T, Yasuno F, Morikawa M, Inoue M, Kiuchi K, Kitamura S, Matsuoka K, Kishimoto T, Kichikawa K, Naganawa S.

Springerplus. 2016 Jul 8;5(1):1023. doi: 10.1186/s40064-016-2692-5. eCollection 2016.

6.

Age and neurodegeneration imaging biomarkers in persons with Alzheimer disease dementia.

Knopman DS, Jack CR Jr, Wiste HJ, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Roberts RO, Boeve BF, Jones DT, Petersen RC.

Neurology. 2016 Jul 15. pii: 10.1212/WNL.0000000000002979. [Epub ahead of print]

PMID:
27421543
7.

European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease-the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow.

Meulenbroek O, O'Dwyer S, de Jong D, van Spijker G, Kennelly S, Cregg F, Olde Rikkert M, Abdullah L, Wallin A, Walsh C, Coen R, Kenny RA, Daly L, Segurado R, Borjesson-Hanson A, Crawford F, Mullan M, Lucca U, Banzi R, Pasquier F, Breuilh L, Riepe M, Kalman J, Molloy W, Tsolaki M, Howard R, Adams J, Gaynor S, Lawlor B.

BMJ Open. 2016 Jul 19;6(7):e011584. doi: 10.1136/bmjopen-2016-011584.

8.

Feasibility and acceptance of simultaneous amyloid PET/MRI.

Schütz L, Lobsien D, Fritzsch D, Tiepolt S, Werner P, Schroeter ML, Berrouschot J, Saur D, Hesse S, Jochimsen T, Rullmann M, Sattler B, Patt M, Gertz HJ, Villringer A, Claßen J, Hoffmann KT, Sabri O, Barthel H.

Eur J Nucl Med Mol Imaging. 2016 Jul 19. [Epub ahead of print]

PMID:
27435367
9.

CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection.

Chen P, Zhao W, Guo Y, Xu J, Yin M.

Biomed Res Int. 2016;2016:8090918. doi: 10.1155/2016/8090918. Epub 2016 Jun 27. Review.

10.

Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels.

Babulal GM, Ghoshal N, Head D, Vernon EK, Holtzman DM, Benzinger TL, Fagan AM, Morris JC, Roe CM.

Am J Geriatr Psychiatry. 2016 Apr 19. pii: S1064-7481(16)30082-3. doi: 10.1016/j.jagp.2016.04.004. [Epub ahead of print]

PMID:
27426238
11.

Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer's disease.

Gispert JD, Suárez-Calvet M, Monté GC, Tucholka A, Falcon C, Rojas S, Rami L, Sánchez-Valle R, Lladó A, Kleinberger G, Haass C, Molinuevo JL.

Alzheimers Dement. 2016 Jul 13. pii: S1552-5260(16)30026-7. doi: 10.1016/j.jalz.2016.06.005. [Epub ahead of print]

PMID:
27423963
12.

Discovery of Novel Biomarkers for Alzheimer's Disease from Blood.

Long J, Pan G, Ifeachor E, Belshaw R, Li X.

Dis Markers. 2016;2016:4250480. doi: 10.1155/2016/4250480. Epub 2016 May 29.

13.

Electrochemical Detection of Amyloid-β Oligomers Based on the Signal Amplification of a Network of Silver Nanoparticles.

Xia N, Wang X, Zhou B, Wu Y, Mao W, Liu L.

ACS Appl Mater Interfaces. 2016 Jul 22. [Epub ahead of print]

PMID:
27414520
14.

Innate phagocytosis by peripheral blood monocytes is altered in Alzheimer's disease.

Gu BJ, Huang X, Ou A, Rembach A, Fowler C, Avula PK, Horton A, Doecke JD, Villemagne VL, Macaulay SL, Maruff P, Fletcher EL, Guymer R, Wiley JS, Masters CL; Australian Imaging, Biomarkers and Lifestyle (AIBL) Study.

Acta Neuropathol. 2016 Jul 13. [Epub ahead of print]

PMID:
27411339
15.

Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile.

Winston CN, Goetzl EJ, Akers JC, Carter BS, Rockenstein EM, Galasko D, Masliah E, Rissman RA.

Alzheimers Dement (Amst). 2016 May 7;3:63-72. doi: 10.1016/j.dadm.2016.04.001. eCollection 2016.

16.

The New Criteria for Alzheimer's Disease - Implications for Geriatricians.

Molin P, Rockwood K.

Can Geriatr J. 2016 Jun 29;19(2):66-73. doi: 10.5770/cgj.19.207. eCollection 2016 Jun.

17.

Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study.

Leuzy A, Chiotis K, Hasselbalch SG, Rinne JO, de Mendonça A, Otto M, Lleó A, Castelo-Branco M, Santana I, Johansson J, Anderl-Straub S, von Arnim CA, Beer A, Blesa R, Fortea J, Herukka SK, Portelius E, Pannee J, Zetterberg H, Blennow K, Nordberg A.

Brain. 2016 Jul 7. pii: aww160. [Epub ahead of print]

18.

Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B.

de Almeida SM, Rotta I, Jiang Y, Li X, Raboni SM, Ribeiro CE, Smith D, Potter M, Vaida F, Letendre S, Ellis RJ; HNRC Group.

J Neurovirol. 2016 Jul 11. [Epub ahead of print]

PMID:
27400932
19.

Femtomolar Detection of Tau Proteins in Undiluted Plasma Using Surface Plasmon Resonance.

Kim S, Wark AW, Lee HJ.

Anal Chem. 2016 Jul 22. [Epub ahead of print]

PMID:
27399254
20.

Imaging and cerebrospinal fluid biomarkers in early preclinical Alzheimer disease.

Vlassenko AG, McCue L, Jasielec MS, Su Y, Gordon BA, Xiong C, Holtzman DM, Benzinger TL, Morris JC, Fagan AM.

Ann Neurol. 2016 Jul 11. doi: 10.1002/ana.24719. [Epub ahead of print]

PMID:
27398953
Items per page

Supplemental Content

Loading ...
Write to the Help Desk